James Healy, Director at Coherus BioSciences, Inc. (CHRS), sold 634,260 shares at $21.37 ($13.6M) on 2019-06-20, disclosed to the SEC on 2019-06-24.
Open-market sale of $13.6M CHRS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.37 | 317,130 | $6.8M | 50.0% |
| 2 | $21.37 | 317,130 | $6.8M | 50.0% |
| Total | $21.37 avg | 634,260 | $13.6M | 100% |
| Filing → |
| RAPP | BUY | 2024-06-10 | $9.5M | — | Filing → |
| AVBP | BUY | 2024-01-31 | $8.0M | — | Filing → |
| NTRA | SELL | 2023-12-22 | $37.8M | — | Filing → |